Based on in vitro and in vivo experimental approaches and extensive quantitative in situ analyses of human breast cancer specimens, we now demonstrate that prolactin activation of prolactin receptors is selectively disrupted even at mildly acidic pHe of 6.8. The gene discussed is PRL; the disease is breast cancer.